Emzahh Gets FDA Approval for Pregnancy Prevention
Emzahh is an AB-rated generic equivalent of Ortho Micronor.
Emzahh is an AB-rated generic equivalent of Ortho Micronor.
Experts discuss strategies to reduce the maternal mortality gap by implementing implicit bias training and reevaluating clinical guidelines and algorithms.
Researchers assessed whether adverse outcomes in women with uncomplicated UTI are more likely when initial antibiotic therapy does not cover the causative uropathogen.
The American College of Physicians updated its 2017 guideline on pharmacologic treatment of osteoporosis or low bone mass to prevent fractures in adults.
Researchers evaluated the efficacy and safety of intermediate-dose vs low-dose low-molecular-weight heparin in pregnant women with a history of venous thromboembolism.
Is prenatal benzodiazepine exposure associated with increased risks for autism spectrum disorder or attention-deficit/hyperactivity disorder?
ACOG experts provide actionable steps to reduce the maternal mortality crisis in the US, particularly among minority populations.
Brexafemme is an oral antifungal agent representing a novel therapeutic class of structurally-distinct glucan synthase inhibitors known as triterpenoids.
The decision to restrict the indication follows an FDA review of the double-blind, placebo-controlled phase 3 ENGOT-OV16/NOVA trial.
The approval was based on data from the SORAYA trial.